Silver sulfadiazine (nanonized) topical - Sun Pharmaceutical

Drug Profile

Silver sulfadiazine (nanonized) topical - Sun Pharmaceutical

Alternative Names: Silver sulfadiazine cream (nanonized)

Latest Information Update: 16 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sun Pharmaceutical Industries
  • Class Antibacterials; Heavy metals; Sulfonamides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Burn infections

Most Recent Events

  • 13 Dec 2016 Sun Pharmaceutical completes a phase III trial in Burn infections in India (Topical) (CTRI2014-11-005188)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top